Papers

6

Total Citations

81

H-Index

5

About

Belal Moftah is a medical physicist whose research is deeply rooted in radiation dosimetry and quality assurance (QA) for advanced radiotherapy systems, with a particular focus on CyberKnife robotic stereotactic radiosurgery. His work addresses one of the most technically demanding challenges in modern radiation oncology: ensuring precise dose delivery in small, irregularly shaped fields where conventional measurement tools often fall short. Moftah's most influential contribution — a 2019 study on three-dimensional polymer gel dosimetry using optical CT, which has garnered 43 citations — introduced innovative approaches to volumetric dose verification that offer superior spatial resolution compared to traditional methods. His broader research portfolio spans angularly independent silicon detectors, high-definition patient-specific QA systems, and comprehensive comparisons of detector technologies including Monte Carlo simulation, Gafchromic film, and scintillators. Together, these studies form a systematic effort to establish reliable, clinically practical QA frameworks for CyberKnife treatments. By rigorously benchmarking emerging detector technologies and dosimetric materials — including novel acrylamide and acrylic acid hydrogels — Moftah has meaningfully advanced the field's capacity to validate complex treatment plans, ultimately contributing to safer and more accurate radiosurgery outcomes for patients worldwide.

Research Focus

Key Achievements

5
H-Index
6
Papers
81
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
3-D Quality Assurance in CyberKnife Radiotherapy Using a Novel N-(3-methoxypropyl) Acrylamide Polymer Gel Dosimeter and Optical CT
43 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: McGill University, King Faisal Specialist Hospital & Research Centre

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago